Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
12.08
+0.15 (1.26%)
Jul 10, 2025, 4:00 PM - Market closed

Adaptive Biotechnologies Market Cap

Adaptive Biotechnologies has a market cap or net worth of $1.84 billion as of July 11, 2025. Its market cap has increased by 278.51% in one year.

Market Cap
1.84B
Enterprise Value
1.82B
1-Year Change
278.51%
Ranking
Category
Stock Price
$12.08

Market Cap Chart

Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $1.84B, a decrease of -61.56%. That is a compound annual growth rate of -14.64%.

History

DateMarket Cap% Change
Jul 10, 20251.84B107.42%
Dec 31, 2024884.74M24.72%
Dec 29, 2023709.39M-35.07%
Dec 30, 20221.09B-72.41%
Dec 31, 20213.96B-51.03%
Dec 31, 20208.09B117.39%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 709.79B
Johnson & Johnson 379.41B
AbbVie 344.45B
Novo Nordisk 316.64B
UnitedHealth Group 271.70B
Novartis AG 243.81B
Abbott Laboratories 232.44B
AstraZeneca 223.49B
Market Cap Rankings